Search Results

While the company’s sales outlook was otherwise rosy, Merck took sales hits on Gardisil, Proquad, Varivax and Vaxneuvance.

Follow along as BioSpace tracks job cuts and restructuring initiatives.

Partnership with “Saffron Tech” to Advance Production of One of the World’s Most Valuable Botanicals Management Concurrently Shares Third Quarter 2025 Preliminary Results and Provides Guidance for the Fourth Quarter of 2025

At Google Cloud’s second annual Cancer AI Symposium, Model Medicines will unveil how its GALILEO™ platform, built on Google Cloud, powered a 325 billion molecule throughput oncology screen — the largest of its kind — opening the door to trillion‑scale discovery and culminating in the discovery of MDL‑4102, a potent and selective BRD4 inhibitor.

Bristol Myers Squibb beat analyst and consensus estimates for the third quarter with $12.2 billion in sales, but executives on the company’s investor call faced questions about a sluggish uptake for schizophrenia drug Cobenfy as well as a highly anticipated Alzheimer’s psychosis readout for the product.

To expand the population for the anti-amyloid Alzheimer’s drugs, Lilly and Biogen are testing presymptomatic patients. Will doctors be open to this paradigm-shifting change?